CervoMed Inc. is a biotechnology company focused on the development of innovative therapies for neurological disorders. The company is dedicated to advancing its proprietary technologies to address a range of unmet medical needs in the field of neurodegenerative diseases. Through rigorous research and clinical trials, CervoMed seeks to improve the lives of patients suffering from conditions that affect the nervous system, aiming to bring transformative solutions to the healthcare market. Read More
Peraso Inc. (NASDAQ: PRSO), a leader in 60GHz mmWave wireless technology, is rapidly expanding its global footprint through dual momentum in defense and broadband sectors. In a key commercial milestone, Tachyon Networks has selected Peraso’s PRM2141X module for its new TNA-303L-65 —a compact outdoor wireless solution delivering fiber-class speeds up to 1 Gbps across 3+ km, without the need for costly trenching.
A look at the top 20 most-searched stocks on Benzinga Pro in March. While many had news in the month that could affect rankings, the trends could be a sign of what's to come.
CervoMed's Phase 2b study extension shows improved cognitive outcomes with neflamapimod, leading to an analyst upgrade and increased confidence in the drug.
Let's have a look at what is happening on the US markets before the opening bell on Thursday. Below you can find the top gainers and losers in today's pre-market session.
